143 related articles for article (PubMed ID: 8609887)
1. Suramin analogues as subtype-selective G protein inhibitors.
Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C
Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of receptor/G protein coupling by suramin analogues.
Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M
Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151
[TBL] [Abstract][Full Text] [Related]
3. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits.
Chung WC; Kermode JC
J Pharmacol Exp Ther; 2005 Apr; 313(1):191-8. PubMed ID: 15626724
[TBL] [Abstract][Full Text] [Related]
4. Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs.
Hohenegger M; Matyash M; Poussu K; Herrmann-Frank A; Sarközi S; Lehmann-Horn F; Freissmuth M
Mol Pharmacol; 1996 Dec; 50(6):1443-53. PubMed ID: 8967964
[TBL] [Abstract][Full Text] [Related]
5. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.
Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328
[TBL] [Abstract][Full Text] [Related]
6. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
7. Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
Hohenegger M; Mitterauer T; Voss T; Nanoff C; Freissmuth M
Mol Pharmacol; 1996 Jan; 49(1):73-80. PubMed ID: 8569715
[TBL] [Abstract][Full Text] [Related]
8. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
9. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
10. Differential uncoupling of A1 adenosine and D2 dopamine receptors by suramin and didemethylated suramin (NF037).
Waldhoer M; Bofill-Cardona E; Milligan G; Freissmuth M; Nanoff C
Mol Pharmacol; 1998 May; 53(5):808-18. PubMed ID: 9584206
[TBL] [Abstract][Full Text] [Related]
11. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes.
Quist E; Satumtira N; Vasan R
Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428
[TBL] [Abstract][Full Text] [Related]
12. The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
Hausmann R; Rettinger J; Gerevich Z; Meis S; Kassack MU; Illes P; Lambrecht G; Schmalzing G
Mol Pharmacol; 2006 Jun; 69(6):2058-67. PubMed ID: 16551782
[TBL] [Abstract][Full Text] [Related]
13. Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes.
Hajek P; Ungemach FR; Abraham G
Pharmacology; 2009; 83(4):247-58. PubMed ID: 19295255
[TBL] [Abstract][Full Text] [Related]
14. Functional role of a C-terminal Gbetagamma-binding domain of Ca(v)2.2 channels.
Li B; Zhong H; Scheuer T; Catterall WA
Mol Pharmacol; 2004 Sep; 66(3):761-9. PubMed ID: 15322269
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
Suzuki E; Kessler M; Montgomery K; Arai AC
Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
[TBL] [Abstract][Full Text] [Related]
16. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
17. Gsalpha-selective G protein antagonists.
Hohenegger M; Waldhoer M; Beindl W; Böing B; Kreimeyer A; Nickel P; Nanoff C; Freissmuth M
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):346-51. PubMed ID: 9419378
[TBL] [Abstract][Full Text] [Related]
18. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.
Meneray MA; Fields TY; Bennett DJ
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
Wise A; Sheehan M; Rees S; Lee M; Milligan G
Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
[TBL] [Abstract][Full Text] [Related]
20. G protein expression in human fetoplacental vascularization. Functional evidence for Gs alpha and Gi alpha subunits.
Bourgeois C; Duc-Goiran P; Robert B; Mondon F; Ferré F
J Mol Cell Cardiol; 1996 May; 28(5):1009-21. PubMed ID: 8762039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
